Stock Information
Soleno Therapeutics Inc (SLNO)
Ticker Symbol: SLNO
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $2,121.01 mil
Piotroski score: 7
PE Ratio: 129.9135
EPS (TTM): 0.1615
Revenue (TTM): $3.20 M
Dividend Yield: N/A%
ROE: 5.9%
Latest News
-
INVESTOR DEADLINE: Soleno Therapeutics, Inc. (SLNO) Investors with Substantial Losses Have Opportunity to Lead the Soleno Class Action Lawsuit- Hagens Berman
Wed, Apr 15, 2026 2:11 PM
-
SOLENO THERAPEUTICS, INC. (SLNO) DEADLINE ALERT Bernstein Liebhard LLP Reminds Soleno Therapeutics, Inc. Investors of Upcoming Deadline
Tue, Apr 14, 2026 11:15 AM
-
SLNO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026
Tue, Apr 14, 2026 9:48 AM
Key Financials
Financial data not available
